Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Patrick F. Williams is Chief Financial Officer at Neuropace. OQRO lists 1 transaction filed with the SEC under this name, the latest on Nov 17, 2026, each linked to the official Form 4.
Chief Financial Officer
Disclosures on record
1
Companies involved
1
Patrick F. Williams bought shares on the open market in 2026 across 2 companies. Sales in 1 of the 6 years since 2021.
Patrick F. Williams reported 1 open-market purchase and 2 sales since 2021; purchases in 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $99K1×1 trade | — |
| 2021 | — | $1.07M2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
NeuropaceNPCE
Nov 17, 2026Bought~$99K
DetailsOfficial recordAs of the latest filing on , Patrick F. Williams reported holding 79,399 shares of Neuropace (NPCE), worth about $633K at the last close of $8 (Nov 16, 2026). In the last 12 months, Patrick F. Williams bought $99K in 1 open-market purchase.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Neuropace NPCE | 79,399 | 79K direct | $8 | $633K | Nov 17, 2026 |
Is this Patrick F. Williams’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Patrick F. Williams reported 0 open-market purchases and 2 sales here, 2021.
Patrick F. Williams reported 1 open-market purchase and 0 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Nov 17, 2026, Patrick F. Williams reported holding 79,399 shares of Neuropace (NPCE). At the last close of $8 on Nov 16, 2026, that is about $633K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Patrick F. Williams reported 1 open-market purchase worth $99K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Patrick F. Williams bought shares on the open market in 2026 across 2 companies. Sales in 1 of the 6 years since 2021.
In SEC filings since 2021: the latest open-market purchase is from 2026; the latest open-market sale is from 2021.
2 companies: Neuropace (NPCE, 2026), STAAR Surgical Company (STAA, 2021).